Health
Newer Type 2 diabetes medications have heart and kidney disease benefits, too – Science Codex
DALLAS, Sept. 28, 2020 — Two newer groups of medications prescribed primarily for Type 2 diabetes treatment (SGLT2 inhibitors and GLP-1 receptor agonists) could significantly reduce risks associated with chronic kidney disease (CKD) and heart disease. Based on analyses of the clinical trials through March 2020, a group of leading experts in diabetes, heart failure, kidney disease and cardiometabolic disease believe the medicines should be considered for people with CKD and Type 2 diabetes to pr…
-
Business15 hours agoWhy is Alphabet stock worth less than Nvidia, Microsoft, Apple, and Amazon even though it is the most profitable S&P 500 company?
-
General21 hours agoMichael Beatty, veteran current affairs journalist and animal welfare advocate, dies aged 76
-
Noosa News14 hours ago‘Sunny, benign’ school holiday weather after morning showers in parts of Queensland
-
Noosa News23 hours agoMissing man, Maroochydore – Queensland Police News